Readycell was in DDI in USA, Seattle

Participating in DDI 2018 in Seattle, USA

Posted by Readycell on June 27, 2018

Comments Off on Participating in DDI 2018 in Seattle, USA
Category: news
Crossing the Atlantic for excellent R&D ReadyCell is committed to keep track of new developments and tendencies within the early drug discovery process, thus we were really glad and excited to participate in to this year’s DDI 2018 conference held in Seattle, between the 14th and 16th of June 2018. Our colleague Dr. Maria Vázquez attended the conference, and met with relevant scientists from many Pharma, Biotech and Academia and discussed the new scenarios within
Meeting in BIOUSA 2018, Boston

Participating in BIOUSA 2018 in Boston, USA

Posted by Readycell on June 14, 2018

Category: news
Developing new trans-Atlantic partnerships June of 2018 has been an important month for ReadyCell, due to our participation in this year’s BIO International Convention held in the city of Boston, Massachusetts, during the 4th – 7th of June. Our colleague Gerard Palau had the chance to meet with Spanish representatives in the Spanish Pavilion, and also, he has met with a remarkable number of scientists, Business Developers, and CEO’s of different Pharma, Biotech and CRO
New Zealand shipping

ReadyCell first shipment to New Zealand

Posted by Readycell on April 23, 2018

Category: news
Looking for an innovative and sophisticated cell-based ready-to-use kit for your permeability and active transport studies? ReadyCell S.L. team is pleased to announce that just today we have completed a successful large distance shipment from our production facilities in Spain to New Zealand. Whatever you are based is not inconvenient for getting our kits in your facilities. Thanks to our Shipping Medium, a novel patented system for in vitro cell preservation, ReadyCell team is capable
Pipette and cells


Posted by Readycell on March 21, 2018

Category: news
R&D Projects: developing different products based on the same cellular origin The main objective for this project involves the completion of the set of HepatoReady products, iniciated in 2014 (Project financed by ACCIÓ, numer RD14 1-0087) and includes the following technical objectives: 1. Develop a method that allows isolated hepatocyte cryopreservation from human tissue, that constitutes a better option for their long term storage, and it offers a permanent supply of product. 2. Develop a
Naiara Valtierra from ReadyCell

Incorporation of new Business Development Manager

Posted by Readycell on January 9, 2018

Category: news
A growing staff for a growing business And yet more news for ReadyCell. We are also really proud to announce another new incorporation, Naiara Valtierra, as a Business Development Manager at ReadyCell. Naiara is a young but yet experienced biotechnologist with an outstanding background in clinical research and in Business Development. You too, Naiara, welcome on board!